Fact file:

Cambridge Biostability Limited

184 Cambridge Science Park
Milton Road
Cambridge CB4 0GA

Telephone: +44 (0)1223 437400
Fax: +44 (0)1223 437437
Web: www.biostability.com

Find this company on the site plan.

CBL has developed a revolutionary technology which formulates vaccines and other biopharmaceuticals into ready-to-inject stable liquid suspensions requiring no refrigeration or reconstitution. CBL’s technology offers significant advantages over existing vaccines by eliminating the cold chain, reducing the cost of administration and increasing vaccine shelf life and effectiveness in the field. The Company has filed seven patent families worldwide and has a number of development programmes underway including a joint venture with Panacea Biotec to develop and market a pentavalent childhood vaccine and collaborations with US Government agencies to develop stable vaccines against botulism and anthrax.

• About
• Park Life
• Park Facilities
• Companies
  • Quicklist
  • Full list
  • Sector
  • My CSP
• Jobs
• News
• Available Property
• Location
• Innovation Centre